Real-time Estimate Cboe Europe 06:25:02 2024-12-10 am EST 5-day change 1st Jan Change
109.60 CHF 0.00% Intraday chart for Medacta Group SA +1.85% -12.42%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Swiss Market Index Advances Ahead of SNB's Rate Decision Day Sep. 25 MT
Medacta Group SA - Analyst/Investor Day Sep. 25
Medacta Group Reports Growth in H1 Attributable Profit, Revenue Sep. 25 MT
Medacta's Profitability at Risk Amid Expected Sales Slowdown in H1, Morgan Stanley Says Sep. 24 MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2024 Sep. 23 CI
Medacta Group, Think Surgical Partner in US for Robotic Total Knee Arthroplasty Solution Aug. 30 MT
Medacta Group, Mighty Oak Medical Settle Patent Dispute via New License Deal Aug. 28 MT
Medacta Group SA, H1 2024 Earnings Call, Jul 25, 2024 Jul. 25
Medacta Group SA Provides Earnings Guidance for the Year 2024 Mar. 13 CI
Medacta Group SA, 2023 Earnings Call, Mar 13, 2024 Mar. 13
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2023 Mar. 12 CI
Medacta Enters Collaboration for RFID Technology in Healthcare Business Feb. 20 MT
Medacta Group SA, 2023 Sales/ Trading Statement Call, Feb 02, 2024 Feb. 02
Medacta Group Books 17% Jump in FY23 Revenue Feb. 02 MT
Medacta to Expand Swiss Facilities to Boost Production Capacity Nov. 30 MT
Medacta Group to Launch Optimized Knee Implant 23-10-30 MT
Medacta's New Study Shows Accuracy of NextAR Shoulder Application 23-10-13 MT
Medacta Group SA, Q2 2023 Earnings Call, Sep 22, 2023 23-09-22
Medacta Group Reports Higher H1 Attributable Profit, Revenue 23-09-22 MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2023 23-09-20 CI
Medacta Group SA, H1 2023 Sales/ Trading Statement Call, Jul 28, 2023 23-07-28
Medacta Posts 21% Increase in H1 Revenue; Raises FY23 Guidance 23-07-28 MT
Medacta Group SA Announces Unaudited Revenue Results for the First Half Ended June 30, 2023 23-07-28 CI
Medacta Group SA Updates Revenue Guidance for the Year 2023 23-07-28 CI
Global markets live: Enel, ASML, Adobe, Nikola... 23-07-05Our Logo
Chart Medacta Group SA
MOVE: Dynamic Chart
Logo Medacta Group SA
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Employees
1,826
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart MEDACTA-GROUP-SAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
118.14EUR
Average target price
150.17EUR
Spread / Average Target
+27.11%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MOVE Stock
  4. News Medacta Group SA
  5. Medacta Group Completes First MyPAO Surgery in Europe